Precigen 2019 SVB Leerink Healthcare Conference Update

Precigen, a subsidiary of Intrexon Corporation (Nasdaq: XON), presented a company update at the 8th Annual SVB Leerink Global Healthcare Conference in February 2019. The presentation outlined Precigen's gene and cell therapy platform, precision bioengineering initiatives, and microbe-based solutions designed to address disease, food production sustainability, and alternative energy systems.